Critic at Large

» genetics & genomics

Most Recent

image: Opinion: Not All Genetic Databases Are Equal

Opinion: Not All Genetic Databases Are Equal

By | December 1, 2016

Sorting out which data sets are clinical-grade is key to helping patients.

0 Comments

image: The Challenges of Precision

The Challenges of Precision

By | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Going Beyond the Lab

Going Beyond the Lab

By | July 1, 2014

Scientists who study the biological roots of sexual orientation should continue working with educators, policy-makers, and the public to put their data to good use.

10 Comments

image: To Study Unfettered

To Study Unfettered

By | July 1, 2014

Researching the causes of sexual orientation should be guided by scientific, not social, concerns.

5 Comments

image: An Open Invitation

An Open Invitation

By | December 1, 2013

On creating communal, equitable discourse to broaden participation in genetics research

3 Comments

image: Proceed with Caution

Proceed with Caution

By | October 1, 2013

While genomic data sharing is essential for research, scientists must work to keep sensitive, potentially damaging information under wraps.

1 Comment

image: Three-Way Parenthood

Three-Way Parenthood

By , , and | October 1, 2013

Avoiding the transmission of mitochondrial disease takes a trio, but raises a host of logistical issues.

2 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Genomics-Informed Pathology

Genomics-Informed Pathology

By | January 1, 2013

Twenty-first century lab reports will include test results read by a new breed of pathologist.

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham